Topic Review
Advancing Tobacco Cessation in Low- and Middle-Income Countries
Tobacco kills more than 8 million people worldwide every year. Over 80% of the world’s 1.3 billion tobacco users live in low- and middle-income countries (LMICs), where the future burden is projected to grow. At the same time, progress in tobacco control has not advanced as far as in many LMICs. In particular, the implementation of tobacco-cessation programs and interventions remains limited. The bulk of the evidence for tobacco-cessation interventions comes from high-income countries and may not reflect the context in LMICs, particularly as resources and training for tobacco cessation are limited.
  • 480
  • 23 Dec 2022
Topic Review
Advantages and Applications of Total-Body PET Scanning
Total-body positron emission tomography (PET)  scanning can not only image faster than traditional techniques with less administered radioactivity but also perform total-body dynamic acquisition at a longer delayed time point based on its ultrahigh detection sensitivity, enhanced temporal resolution, and long scan range (194 cm). These unique characteristics create several opportunities to improve image quality and can provide a deeper understanding regarding disease detection, diagnosis, staging/restaging, response to treatment, and prognostication. 
  • 986
  • 21 Feb 2022
Topic Review
Advantages and Mechanisms of Bacteria for Cancer Therapy
Cancer is one of the major diseases that endanger human health. Bacteria is a novel drug delivery system that has shown great potential in cancer therapy because of its tumor-targeting, oncolytic, and immunomodulatory properties.
  • 204
  • 08 Sep 2023
Topic Review
Advantages of Intranasal Administration in Treatment of Depression
As a mental disease in modern society, depression shows an increasing occurrence, with low cure rate and high recurrence rate. It has become the most disabling disease in the world. At present, the treatment of depression is mainly based on drug therapy combined with psychological therapy, physical therapy, and other adjuvant therapy methods. Antidepressants are primarily administered peripherally (oral and intravenous) and have a slow onset of action. Antidepressant active ingredients, such as neuropeptides, natural active ingredients, and some chemical agents, are limited by factors such as the blood–brain barrier (BBB), first-pass metabolism, and extensive adverse effects caused by systemic administration. The potential anatomical link between the non-invasive nose–brain pathway and the lesion site of depression may provide a more attractive option for the delivery of antidepressant active ingredients.
  • 689
  • 21 Oct 2022
Topic Review
Adverse Cardiovascular Effects of Radiation Therapy
Radiation therapy is a key part of treatment for many cancers. Vast advancements in the field of radiation oncology have led to a decrease in malignancy-related mortality, which has uncovered some of the long-term side effects of radiation therapy. Specifically, there has been an increase in research looking into the cardiovascular side effects of chest radiation therapy for cancers of the esophagus, breast, and lung tissue as well as lymphomas.
  • 173
  • 09 Nov 2023
Topic Review
Adverse Childhood Experiences in Multiple Sclerosis Development
Adverse childhood experiences (ACEs), such as abuse, neglect, and household dysfunction, contribute to long-term systemic toxic stress and inflammation that may last well into adulthood. Such early-life stressors have been associated with increased susceptibility to multiple sclerosis (MS) in observational studies and with the development of experimental autoimmune encephalomyelitis in animal models. ACEs dysregulate neurodevelopment, stress responses, and immune reactivity; they also alter the interplay between the immune system and neural networks. All of this may be relevant for MS risk. 
  • 155
  • 18 Feb 2024
Topic Review
Adverse Health Effects from Lunar Dust Exposure
The respirable fraction of lunar dusts may be toxic to humans. NASA has therefore determined that an exposure standard is necessary to limit the amount of respirable airborne lunar dusts to which astronauts will be exposed. The nominal toxicity that is expected from ordinary mineral dust may be increased for lunar dusts due to the large and chemically reactive surfaces of the dust grains. Human exposures to mineral dusts during industrial operations and from volcanic eruptions give researchers some sense of the relative toxicity of lunar dust, although the Earth-based analogs have serious limitations. Animal and cellular studies provide further evidence that mineral dusts can be somewhat toxic. Earth-based research of mineral dust has shown that freshly fractured surfaces are chemically reactive and can elicit an increased toxic response. Since lunar dust is formed in space vacuum from highly energetic processes, the grain surfaces can be expected to be indefinitely reactive on the lunar surface. NASA predicts that this chemical reactivity will change once the dust is brought into a habitable environment. Dust from lunar soil that was carried into spacecraft during the Apollo missions proved to be a nuisance. The lack of gravity, or the existence of microgravity, increases the time during which dust remains airborne, thereby increasing the probability that these dust particles will be inhaled. Lunar dust particles that are generated by impaction in a deep vacuum have complex shapes and highly reactive surfaces that are coated with a thin layer of vapor-deposited mineral phase. Airborne mineral dust in a variety of forms has been shown to present a serious health hazard to ground-based workers. Crew members who will be at a lunar outpost can be directly exposed to lunar dust in several ways. After crew members perform spacewalks or EVAs, they will introduce into the habitat a large quantity of dust that will have collected on spacesuits and boots. Cleaning of the suits between EVAs and changing of the Environmental Control Life Support System (ECLSS) filters are other operations that could result in direct exposure to lunar dusts. In addition, if the final spacesuit design is based on the current spacesuit design, EVAs may cause dermal injuries, and the introduction of lunar dusts into the suits' interior, which may enhance skin abrasions. When the crew leaves the lunar surface and returns to microgravity, the dust that is introduced into the crew return vehicle will "float," thus increasing the opportunity for ocular and respiratory injury.
  • 320
  • 14 Oct 2022
Topic Review
Adverse Renal Effects of Anticancer Immunotherapy
Modern oncological therapy utilizes various types of immunotherapy. Immune checkpoint inhibitors (ICIs), chimeric antigen receptor T cells (CAR-T) therapy, cancer vaccines, tumor-targeting monoclonal antibodies (TT-mAbs), bispecific antibodies and cytokine therapy improve patients’ outcomes. However, stimulation of the immune system, beneficial in terms of fighting against cancer, generates the risk of harm to other cells in a patient’s body. Kidney damage belongs to the relatively rare adverse events (AEs). Best described, but still, superficially, are renal AEs in patients treated with ICIs. International guidelines issued by the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) cover the management of immune-related adverse events (irAEs) during ICI therapy. 
  • 331
  • 09 Sep 2022
Topic Review
Adverse Side Effects of Long-Term Lithium Therapy
Lithium remains the drug of first choice for prophylactic treatment of bipolar disorder, preventing the recurrences of manic and depressive episodes. The longitudinal experiences with lithium administration greatly exceed those with other mood stabilizers. Among the adverse side effects of lithium, renal, gastrointestinal, neurological, thyroid, metabolic, cognitive, dermatological, cardiologic, and sexual are listed. Probably, the most important negative effect of lithium, occurring mostly after 10–20 years of its administration, is interstitial nephropathy.
  • 514
  • 06 Feb 2023
Topic Review
Advice of Medicine Shortages in Europe
The following recommendations should be considered to handle the issue of drug shortages more effectively in Europe. Since drug shortages do not respect borders and cross-country collaboration would be beneficial for more effective shortage management, a unified European definition and reporting criteria of shortages would be necessary to assure internationally consistent monitoring, reporting, comparisons, responses, and solutions. National authorities across Europe should be aware of shortages through coordinated systems, increasing cross-country transparency, and facilitating solutions in every country. It was a significant step forward in the European Union that in July 2019, the EMA published the “Guidance on detection and notification of shortages of medicinal products for Marketing Authorisation Holders in the Union”. The document contains the effort to facilitate the more uniform reporting and communication of drug shortages and create a harmonization “drug shortage” definition. The document “Good practice guidance for communication to the public on medicines availability issues”contains communication guidelines for the national authorities and the EMA for patients and healthcare professionals.
  • 423
  • 06 Apr 2022
  • Page
  • of
  • 1352
ScholarVision Creations